Skip to main content
Premium Trial:

Request an Annual Quote

Shares in Molecular Devices Fall 17 Percent

Molecular Devices’ stock lost 16.9 percent of its value for the trading week ended Tuesday, following last week’s announcement that it was lowering its revenue guidance for the third quarter (see related article). The firm led all eight decliners for the trading period. Meanwhile, Stratagene shares gained 10.7 percent to lead all issues in the BCW Index.
 
Overall, the Index fell 0.8 percent. In comparison, the Dow Jones Industrial Average rose 0.5 percent and hit an all-time closing high of 11,727.34 on Tuesday. The Nasdaq fell 0.8 percent for the trading period, and the Nasdaq Biotech Index rose 0.6 percent.

 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Current Price
(October 3, 2006)
Last
Price
(September 26, 2006)
% change
Agilent
A
32.24
32.94
-2.1
Applied Biosystems
ABI
32.70
32.34
1.1
Beckman
BEC
57.21
57.58
-0.6
Bio-Rad
BIO
69.86
71.49
-2.3
Bruker
BRKR
7.07
6.69
5.7
Fisher Scientific
FSH
77.66
79.21
-2.0
GE
GE
35.71
35.44
0.8
Invitrogen
IVGN
63.40
63.45
-0.1
Millipore
MIL
60.95
60.41
0.9
Molecular Devices
MDCC
18.15
21.84
-16.9
PerkinElmer
PKI
18.83
18.97
-0.7
Qiagen
QGEN
15.93
15.41
3.4
Sigma
SIAL
75.35
75.25
0.1
Stratagene
STGN
6.95
6.28
10.7
Thermo
TMO
38.93
39.72
-2.0
Waters
WAT
44.88
44.26
1.4
BCW Index Average
40.99
41.33
-0.8
The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.